Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation
Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Tehran University of Medical Sciences
2005-06-01
|
| Series: | International Journal of Hematology-Oncology and Stem Cell Research |
| Assuntos: | |
| Acceso en liña: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|